Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. DE
9. OSIS
10. REAX

Go back to Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer
(NASDAQ: STDY) Delayed: 4.73 --0 (-0%)
Previous Close $4.73    52 Week High $5.21 
Open $0.58    52 Week Low $2.00 
Day High $4.73    P/E N/A 
Day Low $4.73    EPS $0.00 
Volume 102